Total Payments
$6,990
2024 Payments
$401.83
Companies
47
Transactions
427
Medicare Patients
5,107
Medicare Billing
$306,999
Payment Breakdown by Category
Food & Beverage$6,791 (97.2%)
Education$198.37 (2.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,791 | 423 | 97.2% |
| Education | $198.37 | 4 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,187 | 88 | $0 (2024) |
| Astellas Pharma US Inc | $698.35 | 19 | $0 (2024) |
| PFIZER INC. | $652.69 | 47 | $0 (2023) |
| Allergan, Inc. | $480.08 | 26 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $468.40 | 58 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $329.24 | 20 | $0 (2023) |
| Amgen Inc. | $319.55 | 11 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $239.43 | 13 | $0 (2021) |
| Supernus Pharmaceuticals, Inc. | $215.87 | 12 | $0 (2022) |
| Lilly USA, LLC | $196.97 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $401.83 | 23 | ABBVIE INC. ($146.79) |
| 2023 | $595.33 | 36 | AbbVie Inc. ($351.83) |
| 2022 | $750.14 | 54 | ABBVIE INC. ($278.71) |
| 2021 | $1,373 | 78 | AbbVie Inc. ($382.77) |
| 2020 | $901.75 | 52 | Allergan, Inc. ($258.59) |
| 2019 | $916.43 | 66 | Sunovion Pharmaceuticals Inc. ($251.83) |
| 2018 | $873.32 | 40 | Astellas Pharma US Inc ($191.53) |
| 2017 | $1,178 | 78 | Sunovion Pharmaceuticals Inc. ($216.57) |
All Payment Transactions
427 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.58 | General |
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.55 | General |
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.60 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.47 | General |
| 08/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.21 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.48 | General |
| 06/26/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 06/25/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Oncology | ||||||
| 06/05/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $20.39 | General |
| 05/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: NEUROSCIENCE | ||||||
| 05/19/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: ANTI-ANXIETY | ||||||
| 04/16/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: ANTI-ANXIETY | ||||||
| 04/03/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Biological | ||||||
| 03/27/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: PSYCHIATRY | ||||||
| 03/13/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Diabetes | ||||||
| 03/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: NEUROSCIENCE | ||||||
| 02/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Respiratory | ||||||
| 01/31/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $9.34 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 01/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: PSYCHIATRY | ||||||
| 01/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: NEUROSCIENCE | ||||||
| 12/19/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: NEUROSCIENCE | ||||||
| 11/09/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,379 | 35,681 | $252,263 | $102,019 |
| 2022 | 11 | 1,111 | 38,688 | $124,578 | $68,988 |
| 2021 | 14 | 1,320 | 50,477 | $129,113 | $76,836 |
| 2020 | 15 | 1,297 | 54,349 | $120,409 | $59,157 |
Total Patients
5,107
Total Services
179,195
Medicare Billing
$306,999
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 252 | 506 | $80,180 | $29,321 | 36.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 121 | 121 | $21,750 | $14,508 | 66.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 123 | 145 | $37,993 | $12,424 | 32.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 196 | 363 | $40,725 | $11,652 | 28.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 60 | 60 | $18,000 | $9,227 | 51.3% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 38 | 144 | $7,200 | $4,979 | 69.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 38 | 106 | $7,950 | $4,797 | 60.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 56 | 56 | $5,600 | $3,846 | 68.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 266 | 380 | $4,832 | $3,090 | 63.9% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 22 | 40 | $4,000 | $1,426 | 35.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $3,617 | $1,206 | 33.3% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 16 | 29 | $2,900 | $1,010 | 34.8% |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | Office | 2023 | 22 | 22 | $3,300 | $1,003 | 30.4% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 17 | 30 | $2,400 | $879.00 | 36.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 99 | $1,296 | $805.69 | 62.2% |
| J1071 | Injection, testosterone cypionate, 1 mg | Office | 2023 | 14 | 33,279 | $5,265 | $676.01 | 12.8% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 18 | 35 | $955.00 | $559.60 | 58.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 58 | 78 | $2,360 | $265.98 | 11.3% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 18 | 18 | $900.00 | $240.66 | 26.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 18 | 155 | $1,040 | $104.72 | 10.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 186 | 186 | $24,180 | $22,859 | 94.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 249 | 442 | $41,990 | $21,330 | 50.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 231 | 489 | $36,675 | $16,433 | 44.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 41 | 45 | $6,435 | $3,618 | 56.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 22 | 22 | $3,256 | $1,535 | 47.1% |
About Dr. Kash Biddle, DO
Dr. Kash Biddle, DO is a General Practice healthcare provider based in Broken Arrow, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1073566659.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kash Biddle, DO has received a total of $6,990 in payments from pharmaceutical and medical device companies, with $401.83 received in 2024. These payments were reported across 427 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($6,791).
As a Medicare-enrolled provider, Biddle has provided services to 5,107 Medicare beneficiaries, totaling 179,195 services with total Medicare billing of $306,999. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty General Practice
- Location Broken Arrow, OK
- Active Since 05/18/2006
- Last Updated 07/08/2007
- Taxonomy Code 208D00000X
- Entity Type Individual
- NPI Number 1073566659
Products in Payments
- VRAYLAR (Drug) $953.51
- LATUDA (Drug) $468.40
- MYRBETRIQ (Drug) $367.16
- UBRELVY (Drug) $330.25
- JARDIANCE (Drug) $254.31
- CHANTIX (Drug) $240.49
- TRINTELLIX (Drug) $222.70
- Nucynta (Drug) $168.16
- MYDAYIS (Drug) $160.47
- PENNSAID (Drug) $160.14
- QULIPTA (Drug) $154.41
- Aimovig (Biological) $152.98
- JANUVIA (Drug) $134.18
- TROKENDI XR (Drug) $132.28
- Trintellix (Drug) $128.44
- Myrbetriq (Drug) $123.10
- Otezla (Drug) $122.68
- TRELEGY ELLIPTA (Drug) $121.74
- Omnia (Device) $118.51
- REXULTI (Drug) $107.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Broken Arrow
Dr. Wesley Hodge, Dmd, DMD
General Practice — Payments: $1.2M
General Practice $1.2M
Dr. Robert Mongrain, Dmd, DMD
General Practice — Payments: $19,608
General Practice $19,608
Dr. Steve Deem, Dds, DDS
General Practice — Payments: $5,149
General Practice $5,149
Dr. Eric Golbek, Dds, DDS
General Practice — Payments: $3,257
General Practice $3,257
Matthew Lewis, D.d.s, D.D.S
General Practice — Payments: $2,665
General Practice $2,665
Connor Hieger, Dds, DDS
General Practice — Payments: $2,320
General Practice $2,320